Related Experiment Video
Updated: Feb 13, 2026

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Published on: January 25, 2015
Contemporary Treatment Approaches to Sinonasal Mucosal Melanoma
Moran Amit1, Shorook Na'ara2, Ehab Y Hanna3
1Department of Head and Neck Surgery, Unit 1445, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX, 77030, USA.
Abstract:
Sinonasal mucosal melanoma (SNMM) is a rare oncological entity that comprises most head and neck mucosal melanomas. SNMM has distinctive genetic background, different from cutaneous melanoma. Survival outcomes among SNMM patients are poor; while there is no clear consensus on the optimal management of SNMM, the primary treatment modality is generally considered to be wide surgical excision, and radiation therapy (RT) is often used in the postoperative adjuvant setting to improve locoregional control. Systemic therapies have demonstrated little or no survival benefit, and most SNMM patients die of distant metastatic disease. Owing to the rarity of the disease, the literature describing treatment approaches for SNMM is lacking and largely limited to isolated case reports and retrospective series. Here, we describe contemporary diagnostic and therapeutic approaches to SNMM based on the most recent molecular and outcome data.
Insights
Sinonasal mucosal melanoma (SNMM) is a rare cancer with poor survival. Current treatments like surgery and radiation therapy offer limited benefit, highlighting the need for better diagnostic and therapeutic strategies.
Area of Science:
- Oncology
- Head and Neck Surgery
- Melanoma Research
Background:
- Sinonasal mucosal melanoma (SNMM) is a rare malignancy, representing the majority of head and neck mucosal melanomas.
- SNMM exhibits a distinct genetic profile compared to cutaneous melanoma.
- Patients with SNMM generally experience poor survival outcomes.
Purpose of the Study:
- To outline current diagnostic and therapeutic strategies for SNMM.
- To review recent molecular and outcome data relevant to SNMM management.
- To address the lack of comprehensive literature on SNMM treatment approaches.
Main Methods:
- Review of contemporary diagnostic methods for SNMM.
- Analysis of current therapeutic modalities, including surgery and radiation therapy (RT).
- Evaluation of recent molecular and outcome data for SNMM.
Main Results:
- Wide surgical excision is the primary treatment, often followed by adjuvant RT for locoregional control.
- Systemic therapies have shown minimal survival benefit for SNMM patients.
- Distant metastatic disease is the primary cause of mortality in most SNMM cases.
Conclusions:
- Optimal SNMM management lacks consensus, necessitating further research.
- Current treatment approaches, including surgery and RT, have limitations in improving overall survival.
- Advances in understanding SNMM's molecular landscape are crucial for developing effective therapies.
More Related Videos
Related Concept Videos
Contemporary Psychology
Biopsychology
Biopsychology, also known as biological psychology or behavioral neuroscience, focuses on the biological underpinnings of behavior and mental processes. It...
Mucosal Barrier of the Stomach
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Frustration and Conflict: Approach-Approach, Approach-Avoidance
One common type of conflict is the Approach–Approach Conflict. In this case, a person faces two desirable...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

